For the quarterly period ended September 30, 2020 or UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-37856 Medpace Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 32-0434904 (State or other j ...

Medpace Holdings, Inc. (NASDAQ:MEDP) Q3 2020 Earnings Conference Call October 27, 2020 9:00 AM ET Company Participants Kevin Brady ??? Executive Director of Finance August Troendle ??? President and Chief Executive Officer Jesse Geiger ??? Chief Financial Officer and Chief Operating Officer of Laboratory Operations Conference Call Participants John Kreger ??? William Blair Sandy Draper ??? Truist Dave Windley ??? Jefferies Operator Good day, ladies and gentlemen, and welcome to the Medpace Third Quarter Ear ...

| --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------|-------| | | | | | | | INVESTOR PRESENTATION AUGUST J. TROENDLE PRESIDENT & CEO JESSE J. GEIGER & COO, LABORATORY OPERATIONS KEVIN M. BRADY EXECUTIVE DIRECTOR, FINANCE JUNE 2020 | | MAKING THE COMPLEX SEAMLESS FORWARD LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES Forward-Looking Statements This presentation contains forward-looking s ...

| --- | |-------| | | | | | | FORWARD LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES Forward-Looking Statements This presentation contains (overd-colong statements within the reasing of the Pivats Securities Lingslop Reform Ac of 1886. All statements contained in this presentation th considence broward-dooking statements, recluding without invitation statements results and effective tax and effective tax and efective tax and esed for non-G-8-0-P dajustm then address expected foture business and financial ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-37856 Medpace Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 32-0434904 (State or other jurisd ...

Medpace Holdings, Inc. (NASDAQ:MEDP) Q2 2020 Earnings Conference Call July 28, 2020 9:00 AM ET Company Participants Kevin Brady - Executive Director, Finance August Troendle - Chairman, President & CEO Jesse Geiger - CFO & COO, Laboratory Operations Conference Call Participants David Windley - Jefferies John Kreger - William Blair & Company Alexander Draper - SunTrust Robinson Humphrey Operator Good day, ladies and gentlemen, and welcome to the Medpace Second Quarter Earnings Conference Call. [Operator Ins ...

| --- | --- | --- | |-------|-------|-------| | | | | | | | | | | | | FORWARD LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our anticipated financial results ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-37856 Medpace Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 32-0434904 (State or other juris ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Exact name of registrant as specified in its charter) Delaware 32-0434904 (State or other jurisdiction of incorporation or organization) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file numb ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-37856 Medpace Holdings, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incor ...